These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28925481)

  • 1. Functional impact of Galectin-3 and TRAIL expression in breast cancer cells.
    Liu XH; Deng CX; Hu PC; Wang Y; Dong YH
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3626-3633. PubMed ID: 28925481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A galectin-3 sequence polymorphism confers TRAIL sensitivity to human breast cancer cells.
    Mazurek N; Byrd JC; Sun Y; Ueno S; Bresalier RS
    Cancer; 2011 Oct; 117(19):4375-80. PubMed ID: 21446041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstitution of galectin-3 alters glutathione content and potentiates TRAIL-induced cytotoxicity by dephosphorylation of Akt.
    Lee YJ; Song YK; Song JJ; Siervo-Sassi RR; Kim HR; Li L; Spitz DR; Lokshin A; Kim JH
    Exp Cell Res; 2003 Aug; 288(1):21-34. PubMed ID: 12878156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells.
    Oka N; Nakahara S; Takenaka Y; Fukumori T; Hogan V; Kanayama HO; Yanagawa T; Raz A
    Cancer Res; 2005 Sep; 65(17):7546-53. PubMed ID: 16140916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells.
    Li J; Sun RR; Yu ZJ; Liang H; Shen S; Kan Q
    Cancer Biother Radiopharm; 2015 Oct; 30(8):336-41. PubMed ID: 26348206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma.
    Sanlioglu AD; Korcum AF; Pestereli E; Erdogan G; Karaveli S; Savas B; Griffith TS; Sanlioglu S
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):716-23. PubMed ID: 17512128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1 accumulates in the nucleus in response to hypoxia and TRAIL and enhances TRAIL-induced apoptosis in breast cancer cells.
    Fitzgerald LD; Bailey CK; Brandt SJ; Thompson ME
    FEBS J; 2007 Oct; 274(19):5137-46. PubMed ID: 17803681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel targets for sensitizing breast cancer cells to TRAIL-induced apoptosis with siRNA delivery.
    Thapa B; Bahadur Kc R; Uludağ H
    Int J Cancer; 2018 Feb; 142(3):597-606. PubMed ID: 28960310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen and TRAIL synergistically induce apoptosis in breast cancer cells.
    Lagadec C; Adriaenssens E; Toillon RA; Chopin V; Romon R; Van Coppenolle F; Hondermarck H; Le Bourhis X
    Oncogene; 2008 Feb; 27(10):1472-7. PubMed ID: 17767197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin production by breast cancer cells is suppressed by dexamethasone and confers resistance against TRAIL-induced apoptosis.
    Rachner TD; Benad P; Rauner M; Goettsch C; Singh SK; Schoppet M; Hofbauer LC
    J Cell Biochem; 2009 Sep; 108(1):106-16. PubMed ID: 19544400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of MCL1 function sensitizes the MDA-MB-231 breast cancer cells to rh-TRAIL by increasing DR4 levels.
    De Blasio A; Pratelli G; Drago-Ferrante R; Saliba C; Baldacchino S; Grech G; Tesoriere G; Scerri C; Vento R; Di Fiore R
    J Cell Physiol; 2019 Aug; 234(10):18432-18447. PubMed ID: 30912136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration.
    Wang D; Liu D; Gao J; Liu M; Liu S; Jiang M; Liu Y; Zheng D
    FEBS J; 2013 Jul; 280(14):3340-53. PubMed ID: 23647548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamine deprivation sensitizes human breast cancer MDA-MB-231 cells to TRIAL-mediated apoptosis.
    Dilshara MG; Jeong JW; Prasad Tharanga Jayasooriya RG; Neelaka Molagoda IM; Lee S; Park SR; Choi YH; Kim GY
    Biochem Biophys Res Commun; 2017 Apr; 485(2):440-445. PubMed ID: 28202415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells.
    Reinhardt A; Liu H; Ma Y; Zhou Y; Zang C; Habbel JP; Possinger K; Eucker J
    Anticancer Res; 2018 May; 38(5):2669-2682. PubMed ID: 29715087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism.
    Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A
    Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells.
    Sanlioglu AD; Dirice E; Aydin C; Erin N; Koksoy S; Sanlioglu S
    BMC Cancer; 2005 May; 5():54. PubMed ID: 15916713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo--a role in tumour cell survival?
    Holen I; Cross SS; Neville-Webbe HL; Cross NA; Balasubramanian SP; Croucher PI; Evans CA; Lippitt JM; Coleman RE; Eaton CL
    Breast Cancer Res Treat; 2005 Aug; 92(3):207-15. PubMed ID: 16155791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin C promotes apoptosis in breast cancer cells by increasing TRAIL expression.
    Sant DW; Mustafi S; Gustafson CB; Chen J; Slingerland JM; Wang G
    Sci Rep; 2018 Mar; 8(1):5306. PubMed ID: 29593282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of decreased galectin-3 expression and the long-term prognosis in patients with breast cancer.
    Yamaki S; Fujii T; Yajima R; Hirakata T; Yamaguchi S; Fujisawa T; Tsutsumi S; Asao T; Yanagita Y; Iijima M; Kuwano H
    Surg Today; 2013 Aug; 43(8):901-5. PubMed ID: 23090139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch inhibition restores TRAIL-mediated apoptosis via AP1-dependent upregulation of DR4 and DR5 TRAIL receptors in MDA-MB-231 breast cancer cells.
    Portanova P; Notaro A; Pellerito O; Sabella S; Giuliano M; Calvaruso G
    Int J Oncol; 2013 Jul; 43(1):121-30. PubMed ID: 23686163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.